fbpx

Hungarian and international publications and uses of active substances

The official Hungarian and international literature provides a wide range of theoretical background, scientific studies and practical experience on the active ingredients in the product. It is mandatory for the informed consumer to provide information about what he is buying. These information aims to provide consumers with adequate and complete information and to help them make informed and informed choices by outlining the literature on the physiological effects of bile acids and herbal remedies. This information has been prepared in full compliance with the general provisions of Directive 2011/83/EU of the European Parliament and of the Council on consumer protection, the provisions of Directive 2002/46/EC of the European Parliament and of the Council on the labelling of foodstuffs and Directive 2005/29/EC of the European Parliament and of the Council prohibiting unfair business-to-consumer commercial practices, bearing in mind the aim of the legislation to provide consumers with the fullest and most detailed information possible about the product they are buying and its ingredients. The information on the ingredients of the product is for information purposes and does not refer to the overall effects of the product, which are specifically mentioned in the product information.

Use GALLMET products at your own risk and it is recommended that you consult your doctor!

Hungarian literature on the effects of high homocysteine

  1. Assessment of plasma homocysteine levels in ischaemic heart patients - Dr. László Márk, Dr. Ferenc Erdei, Dr. János Márki-Zay, Dr. Erika Nagy, Dr. András Kondacs and Dr. András Katona - Orvosi hetilap 2001.07.29.
  2. Physiological and pathophysiological significance of vitamin B9 - Sára Zsigrai, Alexandra Kalmár, Gábor Valcz, Krisztina Andrea Szigeti, Barbara Kinga Barták, Zsófia Brigitta Nagy, Péter Igaz, Zsolt Tulassay and Béla Molnár
  3. The role of homocysteine in the pathogenesis of early-onset ischaemic heart disease - Dr. Lajos Szollár - Institute of Translational Medicine (Semmelweis University)
  4. Homocysteine - a risk factor for atherosclerosis - László Debreceni, M.D. - Medical Weekly 2001.07.08. issue 27.
  5. A familial co-occurrence of vascular disease, spina bifida and schizophrenia with a heterozygous mutation in a heat-sensitive variant of the MTHFR enzyme - Dr. Adrienn Horváth, Dr. Éva Morava, Dr. Gábor Tóth, Márta Czakó, Dr. Béla Melegh and Dr. György Kosztolányi Medical Weekly 2001.07.08. issue 27.
  6. Metabolic complications of obesity in adolescents, with special reference to the occurrence of elevated uric acid levels - Dr László Ságodi, Dr Viktória Fehér, Dr Emőke Kiss-Tóth, Dr Andrea Almási and Dr László Barkai
  7. The prevalence of diabetic neuropathy and other complications at the University of Debrecen Diabetes Neuropathy Centre - Dr. Ferenc Sztanek, Dr. Bernadett Balogh, Dr. Ágnes Molnár, Dr. Eszter Zöld, Dr. Nóra Tóth, Dr. Áron András Jakab and Dr. György Paragh
  8. About the ophthalmic complications of diabetes - About diabetic retinopathy and macular edema

International literature on the effects of high homocysteine levels

  1. New Evidence for Homocysteine Lowering for Management of Treatment-Resistant Hypertension - Merrill F. Elias and Craig J. Brown
  2. Homocysteine - from disease biomarker to disease prevention - Smith AD, Refsum H.
  3. Using data mining technology to explore homocysteine at low levels - Tseng FC, Huang TC.
  4. Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person - Koklesova L, Mazurakova A, Samec M, Biringer K, Samuel SM, Büsselberg D, Kubatka P, Golubnitschaja O.
  5. Homocysteine and the SARS-CoV-2 Coronavirus - the X Factor of Severe Disease and Death - Nancy Lord & Mary Ruwart
  6. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015 - Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, Ahmed M, Aksut B, Alam T, Alam K, Alla F, Alvis-Guzman N, Amrock S, Ansari H, Ärnlöv J, Asayesh H, Atey TM, Avila-Burgos L, Awasthi A, Banerjee A, Barac A, Bärnighausen T, Barregard L, Bedi N, Belay Ketema E, Bennett D, Berhe G, Bhutta Z, Bitew S, Carapetis J, Carrero JJ, Malta DC, Castañeda-Orjuela CA, Castillo-Rivas J, Catalá-López F, Choi JY, Christensen H, Cirillo M, Cooper L, Criqui M, Cundiff D, Damasceno A, Dandona L, Dandona R, Davletov K, Dharmaratne S, Dorairaj P, Dubey M, Ehrenkranz R, El Sayed Zaki M, Faraon EJA, Esteghamati A, Farid T, Farvid M, Feigin V, Ding EL, Fowkes G, Gebrehiwot T, Gillum R, Gold A, Gona P, Gupta R, Habtewold TD, Hafezi-Nejad N, Hailu T, Hailu GB, Hankey G, Hassen HY, Abate KH, Havmoeller R, Hay SI, Horino M, Hotez PJ, Jacobsen K, James S, Javanbakht M, Jeemon P, John D, Jonas J, Kalkonde Y, Karimkhani C, Kasaeian A, Khader Y, Khan A, Khang YH, Khera S, Khoja AT, Khubchandani J, Kim D, Kolte D, Kosen S, Krohn KJ, Kumar GA, Kwan GF, Lal DK, Larsson A, Linn S, Lopez A, Lotufo PA, El Razek HMA, Malekzadeh R, Mazidi M, Meier T, Meles KG, Mensah G, Meretoja A, Mezgebe H, Miller T, Mirrakhimov E, Mohammed S, Moran AE, Musa KI, Narula J, Neal B, Ngalesoni F, Nguyen G, Obermeyer CM, Owolabi M, Patton G, Pedro J, Qato D, Qorbani M, Rahimi K, Rai RK, Rawaf S, Ribeiro A, Safiri S, Salomon JA, Santos I, Santric Milicevic M, Sartorius B, Schutte A, Sepanlou S, Shaikh MA, Shin MJ, Shishehbor M, Shore H, Silva DAS, Sobngwi E, Stranges S, Swaminathan S, Tabarés-Seisdedos R, Tadele Atnafu N, Tesfay F, Thakur JS, Thrift A, Topor-Madry R, Truelsen T, Tyrovolas S, Ukwaja KN, Uthman O, Vasankari T, Vlassov V, Vollset SE, Wakayo T, Watkins D, Weintraub R, Werdecker A, Westerman R, Wiysonge CS, Wolfe C, Workicho A, Xu G, Yano Y, Yip P, Yonemoto N, Younis M, Yu C, Vos T, Naghavi M, Murray C.
  7. Elevated homocysteine levels in patients with heart failure: a systematic review and meta-analysis - Jin N, Huang L, Hong J, Zhao X, Chen Y, Hu J, Cong X, Xie Y, Pu J.
  8. PON1 status and homocysteine levels as potential biomarkers for cardiovascular disease - Ponce-Ruiz N, Murillo-González FE, Rojas-García AE, Barrón-Vivanco BS, Bernal-Hernández YY, González-Arias CA, Ortega-Cervantes L, Ponce-Gallegos J, López-Guarnido O, Medina-Díaz
  9. The association between homocysteine levels and cardiovascular disease risk among middle-aged and elderly adults in Taiwan. - Shih CC, Shih YL, Chen JY.
  10. Hyperhomocysteinemia as an Independent Risk Factor for Coronary Heart Disease: Comparison with Conventional Risk Factors. - Muzaffar R, Khan MA, Mushtaq MH, Nasir M, Khan A, Haq IU, Muhammad J.
  11. Impaired Homocysteine Metabolism and Atherothrombotic Disease - Philippe Durand, Michel Prost, Nadine Loreau, Suzanne Lussier-Cacan, and Denis Blache
  12. Homocysteine accelerates endothelial cell senescence - Dong Xua, Richard Nevilleb, Toren Finkela
  13. New Evidence for Homocysteine Lowering for Management of Treatment-Resistant Hypertension - Merrill F. Elias and Craig J. Brown.
  14. Endothelial Dysfunction: The Link Between Homocysteine and Hydrogen Sulfide - Sathnur Pushpakumar, Sourav Kundu and Utpal Sen
  15. Low Dose Betaine Supplementation Leads to Immediate and Long Term Lowering of Plasma Homocysteine in Healthy Men and Women - Margreet R. Olthof, Trinette van Vliet, Esther Boelsma and Petra Verhoef
  16. Health Functionalities of Betaine in Patients With Homocystinuria - Truitt C, Hoff WD, Deole R.
  17. Prognostic Genetic Markers for Thrombosis in COVID-19 Patients: A Focused Analysis on D-Dimer, Homocysteine and Thromboembolism - Mohamed Abu-Farha, Salman Al-Sabah, Maha M. Hammad, Prashantha Hebbar, Arshad Mohamed Channanath, Sumi Elsa John, Ibrahim Taher, Abdulrahman Almaeen, Amany Ghazy, Anwar Mohammad, Jehad Abubaker, Hossein Arefanian, Fahd Al-Mulla and Thangavel Alphonse Thanaraj
  18. Severe Acute Respiratory Syndrome Coronavirus 2 Infection is Associated with Homocysteine Levels and Clinical Outcomes in Ischemic Stroke Patients - Syahrul Syahrul, Imran Imran, Nasrul Musadir and Vivi Keumala Mutiawati
  19. Homocysteine as a marker for predicting disease severity in patients with COVID-19 - Adem Keskin, Goksenin U Ustun, Recai Aci and Utku Duran
  20. COVID-19 spreading across world correlates with C677T allele of the methylenetetrahydrofolate reductase (MTHFR) gene prevalence - Giovanni Ponti, Lorenza Pastorino, Marco Manfredini, Tomris Ozben, Gabriella Oliva, Shaniko Kaleci, Raffaele Iannella and Aldo Tomasi
  21. Impaired Folate-Mediated One-Carbon Metabolism in Type 2 Diabetes, Late-Onset Alzheimer's Disease and Long COVID - Melvin R. Hayden and Suresh C. Tyagi
  22. COVID-19: A methyl-group assault? - Andrew McCaddon, Björn Regland
  23. Effect of an aqueous extract of Terminalia chebula on endothelial dysfunction, systemic inflammation, and lipid profile in type 2 diabetes mellitus: A randomized double-blind, placebo-controlled clinical study - Usharani Pingali, Deepasree Sukumaran, Chandrasekhar Nutalapati
  24. Hypolipidemic Effect of Triphala in Experimentally Induced Hypercholesteremic Rats - Selvaraj Saravanan, Ramasundaram Srikumar, Sundaramahalingam Manikandan, Narayanaperumal Jeya Parthasarathy and Rathinasamy Sheela Devi
  25. Elevated Intakes of Supplemental Chromium Improve Glucose and Insulin Variables in Individuals With Type 2 Diabetes - Richard A. Anderson, Nanzheng Cheng, Noella A. Bryden, Marilyn M. Polansky, Nanping Cheng, Jiaming Chi and Jinguang Feng
  26. Chromium, Glucose Intolerance and Diabetes - Richard A. Anderson
  27. The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects - Raymond Press MD, Jack Geller MD And Gary W. Evans PhD
  28. Beneficial Effect of Chromium Supplementation on Serum Triglyceride Levels in NIDDM - Nancy A. Lee MD, Charles A. Reasner MD
  29. Homocysteine Induces Inflammation in Retina and Brain - Nehal M. Elsherbiny, Isha Sharma, Dina Kira, Suhib Alhusban, Yara A. Samra, Ravirajsinh Jadeja, Pamela Martin, Mohamed Al-Shabrawey and Amany Tawfik
  30. Homocysteine and Dementia: An International Consensus Statement - A. David Smith, Helga Refsum, Teodoro Bottiglieri, Michael Fenech, Babak Hooshmand, Andrew McCaddon, Joshua W. Miller, Irwin H. Rosenberg and Rima Obeid
  31. Vitamin B6 Fact Sheet for Health Professionals - National Institutes of Health
  32. Folic acid supplementation improves cognitive function by reducing the levels of peripheral inflammatory cytokines in elderly Chinese subjects with MCI - Fei Ma, Tianfeng Wu, Jiangang Zhao, Aili Song, Huan Liu, Weili Xu and Guowei Huang
  33. The Different Relationship between Homocysteine and Uric Acid Levels with Respect to the MTHFR C677T Polymorphism According to Gender in Patients with Cognitive Impairment - Hee-Jin Kim, Il Woong Sohn, Young Seo Kim and Jae-Bum Jun
  34. Homocysteine and Depression in Later Life - Teodoro Bottiglieri, Malcolm Laundy, Richard Crellin, Brian K Toone, Michael W P Carney, Edward H Reynolds
  35. Homocysteine, folate, methylation, and monoamine metabolism in depression - Osvaldo P. Almeida MD PhD, FRANZCP, Kieran McCaul PhD, Graeme J. Hankey MD, FRACP et al
  36. Serum Homocysteine Level in Parkinson's Disease and Its Association with Duration, Cardinal Manifestation, and Severity of Disease - Payam Saadat, Alijan Ahmadi Ahangar, Seyed Ehsan Samaei, Alireza Firozjaie, Fatemeh Abbaspour, Sorrayya Khafri and Azam Khoddami
  37. Elevated Serum Homocysteine Levels Have Differential Gender-Specific Associations with Motor and Cognitive States in Parkinson's Disease - Megan C. Bakeberg, Alexa Jefferson, Maddeson Riley, Michelle Byrnes, Soumya Ghosh, Frank L. Mastaglia, Malcom K. Horne, Sarah McGregor, Rick Stell, Jade Kenna, Sue Walters and Dana Hince et al.
  38. A Review on Potential Mechanisms of Terminalia chebula in Alzheimer's Disease - Amir R. Afshari, Hamid R. Sadeghnia and Hamid Mollazadeh
  39. MTHFR C677T polymorphism and risk of esophageal cancer: an updated meta-analysis - Pradeep Kumar, Vandana Rai
  40. The association between MTHFR polymorphism and cervical cancer - Jiao-Mei Gong, Yong Shen, Wan-Wan Shan and Yan-Xia He
  41. MTHFR C677T polymorphism and breast, ovarian cancer risk - Pradeep Kumar, Vandana Rai
  42. Elevated Homocysteine Levels Are Associated With the Metabolic Syndrome and Cardiovascular Events in Hypertensive Patients - Cristiana Catena, Gianluca Colussi, Francesca Nait, Frine Capobianco and Leonardo A. Sechi
  43. Association between plasma homocysteine and progression of early nephropathy in type 2 diabetic patients - Huan Wang, Kai Cui, Ke Xu, and Shixin Xu
  44. Chromium, Glucose Intolerance and Diabetes - Richard A. Anderson PhD
  45. Homocysteine in Renal Injury - Yanjun Longa and Jing Niea
  46. Elevated Serum Homocysteine Levels Were Not Correlated with Serum Uric Acid Levels, but with Decreased Renal Function in Gouty Patients - Sang Tae Choi, Jin Su Kim and Jung-Soo Song
  47. Serum Homocysteine Level Is Positively Correlated With Serum Uric Acid Level in U.S. Adolescents: A Cross Sectional Study - Yumeng Shi, Zuxiang Wu, Ji Wu, Zhiqiang Chen and Ping Li
  48. Folic acid therapy reduces serum uric acid in hypertensive patients: a substudy of the China Stroke Primary Prevention Trial (CSPPT) - Xianhui Qin, Youbao Li, Mingli He, Genfu Tang, Delu Yin, Min Liang, Binyan Wang, Jing Nie, Yong Huo, Xin Xu and Fan Fan Hou
gallmet.hu
en_GBEnglish (UK)